More Business Wire
View Older Stories View Newer Stories-
Avenacy to Attend J.P. Morgan 43rd Annual Healthcare Conference
-
Beat the Winter Beauty Slump With WOW Skin Science's Curl-Reviving Solutions
-
Transcend Partners with Microsoft to Bring Seamless Data Governance to the Enterprise
-
Armanino Foods of Distinction, Inc. to Maintain Its Highest Ever Regular Quarterly Dividend at $0.0363 and Announces Change in Auditors
-
Apex Clean Energy Closes Financing for 300 MW Prosperity Wind
-
Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director
-
Personalis and Tempus Expand Collaboration to Biopharma
-
Airspan Networks Partners With AWTG to Enhance Railway Connectivity in the UK Through 5G Innovation
-
Redfin Reports Asking Rents for Newly Built Apartments Rise 1.5%, the Biggest Spike in 18 Months
-
Chase Freedom® Celebrates 15 Years of Rotating Cash Back Categories, Kicking Off 2025 With: Norwegian Cruise Lines, Grocery Stores, Fitness Clubs and Self-Care Services
-
AIM ImmunoTech Reminds Shareholders to Vote “FOR” All Four Incumbent Board Members on the WHITE Universal Proxy Card
-
Morris & Dickson Announces 2025 Health System Advisory Board
-
ON24 Awarded the TrustRadius 2025 Buyer’s Choice Award for Enterprise Excellence
-
Slate Grocery REIT Announces Distribution for the Month of December 2024
-
Delta Galil Announces Confidential Submission of Draft Registration Statement for a Proposed U.S. Initial Public Offering
-
Viamericas and Banco G&T Double Annual Viamistad Donation Campaign to Provide Educational and Recreational Camps for Guatemalans with Disabilities
-
ISACA Research Finds Only 41 Percent of Businesses Have Programs in Place to Hire More Women in Tech
-
FairJourney Biologics Establishes Scientific Advisory Board
-
Varex Announces Private Offering of $125 Million of Senior Secured Notes
-
SaaS Data Protection and Backup Leader Keepit Secures $50M in Funding to Accelerate Growth and Product Innovation
-
FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older
-
Realbotix Partners with Compass UOL, Receives Amazon Development Subsidy and Provides Update on Aria
-
Pattern Energy Announces Equity Investment from Consortium Headed by APG and ART
-
FIDE World Rapid & Blitz Chess Championship Announces Full List of Players Competing for World Title
-
Phillips 66 announces agreement to sell interest in Gulf Coast Express
-
Fibracast Appoints Michael Leach as Vice President of North American Sales
-
MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)
-
Performance Food Group Company Announces Executive Leadership Team Changes
-
Candid Therapeutics and Ab Studio Enter Into Research Collaboration to Discover and Develop Novel T Cell Engagers for Autoimmune Indications
-
NMG Appoints Chantal Sorel to Its Board of Directors
-
D-Wave CEO Dr. Alan Baratz Discusses Company’s Growing Commercial Quantum Computing Momentum on Yahoo! Finance's “Catalysts”
-
Pebblebrook Hotel Trust Declares Dividends for Fourth Quarter 2024
-
BlackRock 2025 Private Markets Outlook: A New Era of Growth
-
Fluid Biomed Inc. Raises $27 Million USD in Oversubscribed Series A Financing to Advance World’s First Bioabsorbable Polymer-Based Stent To Treat Brain Aneurysms
-
Bridgewater Bancshares, Inc. Completes Acquisition of First Minnetonka City Bank
-
Only 41 Percent of Businesses Have Programs in Place to Hire More Women in Tech, According to ISACA Research
-
Viridian Therapeutics Announces Positive Topline Results from Veligrotug Phase 3 THRIVE-2 Clinical Trial in Patients with Chronic Thyroid Eye Disease
-
Phillips 66 announces 2025 capital program
-
Total Economic Impact Study Reveals 204% ROI for SymphonyAI Enterprise IT Service Management Customers
-
Candid Therapeutics and EpimAb Biotherapeutics Enter Into Research Collaboration to Discover and Develop Novel T-Cell Engagers for Autoimmune Indications
-
KalVista Appoints Jeb Ledell as Chief Operating Officer
-
Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)
-
VectorY Strengthens Leadership Team with Appointment of Jim Scibetta as New CEO
-
Orbus Software Announces Strategic Growth Investment from FTV Capital and SilverTree Equity
-
Vantage Data Centers Announces €1.4B Investment in the Company’s EMEA Data Center Platform
-
Biocodex Strengthens Supply Chain Resilience with Kinaxis
-
Vitesse Energy to Acquire Lucero Energy in Accretive All-Stock Transaction Supporting Increase to Vitesse’s Dividend
-
Iron County School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students
-
The Coca-Cola Company Announces Retirement of Director
-
Dollar General Releases Holiday Deals for December 16-24 - Final Days of DG’s 24 Days of Savings
